1N6B

Microsomal Cytochrome P450 2C5/3LVdH Complex with a dimethyl derivative of sulfaphenazole

1N6B の概要

• エントリーDOI: 10.2210/pdb1n6b/pdb
• 関連するPDBエントリー: 1DT6
• 分子名称: Cytochrome P450 2C5, SULFATE ION, PROTOPORPHYRIN IX CONTAINING FE, ... (5 entities in total)
• 機能のキーワード: membrane protein, progesterone 21-hydroxylase, benzo(a), pyrene hydroxylase, estradiol 2-hydroxylase, p450, cyp2c5, dimethylsulfaphenazole complex, oxidoreductase
• 由来する生物種: Oryctolagus cuniculus (rabbit)
• 細胞内の位置: Endoplasmic reticulum membrane (By similarity): P00179
• タンパク質・核酸の鎖数: 1
• 化学式量合計: 55020.26

構造登録者

Wester, M.R.,Johnson, E.F.,Marques-Soares, C.,Dansette, P.M.,Mansuy, D.,Stout, C.D. (登録日: 2002-11-09, 公開日: 2003-06-03, 最終更新日: 2024-02-14)

主引用文献

Wester, M.R.,Johnson, E.F.,Marques-Soares, C.,Dansette, P.M.,Mansuy, D.,Stout, C.D.
Structure of a Substrate Complex of Mammalian Cytochrome P450 2C5 at 2.3 A Resolution: Evidence for Multiple Substrate Binding Modes
Biochemistry, 42:6370-6379, 2003

PubMed Abstract: The structure of rabbit microsomal cytochrome P450 2C5/3LVdH complexed with a substrate, 4-methyl-N-methyl-N-(2-phenyl-2H-pyrazol-3-yl)benzenesulfonamide (DMZ), was determined by X-ray crystallography to 2.3 A resolution. Substrate docking studies and electron density maps indicate that DMZ binds to the enzyme in two antiparallel orientations of the long axis of the substrate. One orientation places the principal site of hydroxylation, the 4-methyl group, 4.4 A from the heme Fe, whereas the alternate conformation positions the second, infrequent site of hydroxylation at >5.9 A from the heme Fe. Comparison of this structure to that obtained previously for the enzyme indicates that the protein closes around the substrate and prevents open access of water from bulk solvent to the heme Fe. This reflects a approximately 1.5 A movement of the F and G helices relative to helix I. The present structure provides a complete model for the protein from residues 27-488 and defines two new helices F' and G'. The G' helix is likely to contribute to interactions of the enzyme with membranes. The relatively large active site, as compared to the volume occupied by the substrate, and the flexibility of the enzyme are likely to underlie the capacity of drug-metabolizing enzymes to metabolize structurally diverse substrates of different sizes.

PubMed: 12767218
DOI: 10.1021/bi0273922

実験手法

X-RAY DIFFRACTION (2.3 Å)